Background: Chronic ethanol (EtOH) consumption is a major cause of liver disease worldwide. Oxidative stress is a known consequence of EtOH metabolism and is thought to contribute significantly to alcoholic liver disease (ALD). Therefore, elucidating pathways leading to sustained oxidative stress and downstream redox imbalances may reveal how EtOH consumption leads to ALD. Recent studies suggest that EtOH metabolism impacts mitochondrial antioxidant processes through a number of proteomic alterations, including hyperacetylation of key antioxidant proteins.
E THANOL (ETOH) CONSUMPTION is currently the fourth highest preventable cause of death in the United
States and is a severe public health concern (CDC, 2013; Mokdad et al., 2004) . Furthermore, EtOH is a significant hepatotoxicant and oxidative stress plays a central role in the pathogenesis of alcoholic liver disease (ALD) ). Oxidative stress is defined as an imbalance between pro-oxidants and antioxidants, resulting in dysregulated redox signaling and control (Jones, 2006) . This persistent oxidative imbalance can alter redox sensitive pathways and can result in damage to cellular macromolecules, including lipids, proteins, and DNA, when reactive oxygen species are in excess Lobo et al., 2010) . Elucidating cellular mechanisms of altered hepatic redox homeostasis due to EtOH metabolism is essential to understanding the initiation and progression of ALD.
In addition to oxidative stress, chronic EtOH metabolism significantly perturbs mitochondrial metabolic pathways and induces protein hyperacetylation (Fritz et al., 2012; Picklo, 2008; Shepard et al., 2010; Shukla and Aroor, 2006) . Mitochondrial lysine acetylation is regarded as a footprint of metabolic status as demonstrated in a model of caloric restriction, arising in part, as a consequence of altered acetylCoA flux through glycolysis and lipid metabolism (Hebert et al., 2013; Pougovkina et al., 2014; Shi and Tu, 2015) . The acetylation of lysine residues has also recently been described as an important posttranslational modification (PTM) that can modulate protein activity, protein-protein interactions, protein turnover, and cell cycle progression (Friedmann and Marmorstein, 2013) . Last, in a number of instances, lysine acetylation has been shown to suppress the enzymatic activity of critical mitochondrial proteins, including those relevant to antioxidant defense, thus supporting our hypothesis that EtOH-induced mitochondrial protein hyperacetylation may inhibit critical antioxidant processes (Baeza et al., 2016) .
A number of original reports characterized EtOHinduced changes in protein acetylation (Picklo, 2008; Shepard et al., 2010; Shukla and Aroor, 2006) . Recently, our laboratory demonstrated that mitochondrial superoxide dismutase (SOD2) is an acetylation target that is hyperacetylated as a result of EtOH consumption (Fritz et al., 2012) . Additionally, several studies have shown that SOD2 enzymatic activity is negatively altered through acetylation of lysine residues. For instance, Zhu and colleagues (2012) demonstrated that acetylation of SOD2 K122 decreased the enzymatic activity via masking the positively charged amino acids of the active site. Lu and colleagues (2015) also showed that acetylation of SOD2 K68 reduced its activity via modulating structure and charge state. SOD is responsible for detoxifying superoxide radicals by catalyzing the conversion of the superoxide anion into hydrogen peroxide and molecular oxygen. Hydrogen peroxide is then further converted into H 2 O and molecular oxygen via both enzymatic and nonenzymatic processes (Lobo et al., 2010) . In mammals, SOD is present as 3 isoforms that differentially localize within the cell: SOD1 in the cytoplasm, SOD2 in the mitochondria, and SOD3 in the extracellular matrix (Miao and St Clair, 2009 ). SOD2 is the major mitochondrial antioxidant enzyme that prevents oxidative damage resulting from the generation and accumulation of superoxide radicals (Flynn and Melov, 2013) . Mice with inactivated SOD2 die prematurely and exhibit severe mitochondrial defects, demonstrating this enzyme's critical importance in sustaining life (Melov et al., 2001) . Interestingly, overexpression of SOD2 prevented liver damage due to EtOH metabolism by neutralizing certain toxicological markers such as glutathione (GSH) oxidation, alanine aminotransferase (ALT) elevation, and the formation of free radical adducts in bile (Wheeler et al., 2001) . Furthermore, SOD2 overexpression also ameliorated alcohol-induced pathologies like steatosis, necrosis, apoptosis, and inflammation (Wheeler et al., 2001) . Another study demonstrated that chronic alcohol feeding slightly reduced hepatic SOD2 activity; however, the exact mechanism was not revealed (Roede et al., 2009) .
EtOH metabolism increased protein acetylation within the mitochondria, which may represent a critical mechanism underlying an altered mitochondrial state (Fritz et al., 2013) . This study examines the effect of EtOH-induced protein hyperacetylation on SOD2, a protein with 16 lysine residues prone to acetylation. Importantly, it has been reported that SOD2 K68 and K122 are key regulators of enzymatic activity due to alterations in protein charge-state dynamics (Lu et al., 2015; Ozden et al., 2011; Zhu et al., 2012; Zou et al., 2016) . As oxidative stress is a central mechanism of EtOHinduced liver injury, and we previously observed SOD2 hyperacetylation upon EtOH administration, we investigated the hypothesis that chronic EtOH consumption increases SOD2 acetylation, leading to alterations in SOD2 protein structure and activity, potentially contributing to overall mitochondrial dysregulation and the progression of ALD (Fritz et al., 2012) .
MATERIALS AND METHODS

Animal Studies
Animal studies were approved by the Institutional Animal Care and Use Committee of the University of Colorado. Male C57BL/ 6J mice (8 to 12 weeks old) were purchased from Jackson Laboratories (Bar Harbor, ME) for chronic EtOH feeding as previously described (Fritz et al., 2013) . Briefly, 12 mice were fed a modified Lieber-DeCarli liquid diet (Bio-Serv, Frenchtown, NJ) for 6 weeks, where EtOH was ramped from 1% to 6% (v/v) over the 6-week period. After 6 weeks, mice were anesthetized via an intraperitoneal injection of pentobarbital (65 mg/kg). Tissues were either collected and flash-frozen for biochemical analysis, or formalin-fixed for histopathology assessment. An aliquot of liver tissue was extracted and weighed, and subcellular fractionation was performed as previously described (Harris et al., 2015) . Oxidized and reduced glutathione was measured via high-performance liquid chromatography (HPLC) and fluorescence detection as previously detailed (Harris et al., 2015) .
Immunohistochemistry
Freshly excised liver tissues were fixed in 10% formalin (Sigma, St. Louis, MO) overnight. The tissue was then embedded in paraffin, cut, and mounted on slides by the University of Colorado Anschutz Medical Campus Histology Core. Standard hematoxylin and eosin (H&E) staining was performed. Immunohistochemistry (IHC) was performed using the ABC citrate antigen retrieval system (Vector Labs, Burlingame, CA) and by incubating liver tissue sections with primary antibodies raised against CYP2E1 (AB1252; Millipore, Darmstadt, Germany), SOD2 (ab13534; Abcam, Cambridge, MA), and SOD2 acetyl-K68 (ab137037; Abcam) overnight at 4°C via a protocol described by Harris and colleagues (2015) . Histologic images were captured on an Olympus BX51 (Waltham, MA) microscope equipped with a 4 megapixel Macrofire digital camera using the PictureFrame Application 2.3 (Optronics, Goleta, CA ). All images were cropped and assembled using Photoshop CS2 (Adobe Systems, Inc., San Jose, CA). Images were then imported into Slidebook (3I, Denver, CO) for quantification, which was performed on 5 images per animal, 3 to 4 animals per group.
Western Blotting
Protein samples (10 to 60 lg) from EtOH-and pair-fed controls were separated using 12% SDS-PAGE at 150 V for 1 hour and then transferred to activated Hybond-PVDF membrane (GE Healthcare, Buckinghamshire, UK). Membranes were blocked using 5% (w/v) nonfat dry milk in Tris-buffered saline-Tween 20 TBS/0.1% (v/v) Tween (TBS-T) for 1 hour at room temperature. Membranes were incubated with primary antibodies against SOD2 (ab13534), SOD2 acetyl K68 (ab137037), or SOD2 acetyl K122 (ab214675) (Abcam) overnight at 4°C and then washed 3 times with TBS-T, and incubated with horseradish peroxidase-conjugated secondary antibody at room temperature for 1 hour. Membranes were washed again with TBS-T 3 times, and then Clarity Western ECL Substrate (Bio-Rad, Hercules, CA) was applied before imaging via Chemidoc Ò MP (Bio-Rad). 2,2,2-trichloroethanol (Sigma) stain was used to visualize overall protein load.
Two-dimensional (2D) SDS-PAGE was performed using 200 lg of liver whole cell extract and was separated on IPG strips (pH 3-11) (Bio-Rad) and then resolved using 10% SDS-PAGE. The proteins were then transferred onto PVDF membrane and probed with anti-SOD2 (ab13534) and SOD2 acetyl-K68 (ab137037) antibody (Abcam) using standard Western blot analysis as described above.
SOD2 Activity Assay
In vitro SOD2 activity was performed using 1 lg of murine recombinant SOD2 (Enzo, Farmingdale, NY). SOD2 was incubated with and without increasing concentrations of acetic anhydride for 1 hour at room temperature to induce protein acetylation, and then, the activity assay was performed according to the manufacturer's protocol (Cayman, Ann Arbor, MI).
In vivo SOD2 activity was measured in mitochondria enriched fractions from control and EtOH-fed mice. Protein concentration was measured using the BCA assay (Thermo Scientific, Rockford IL). Samples were diluted to (10 lg/ll), and 20 mM of KCN (Sigma) was added to each sample and then incubated for 1 hour to eliminate trace activity from SOD1 and SOD3. SOD2 activity was measured using the method previously described by Misra and Fridovich (1972) .
In Vitro Acetylation
To determine preferential sites of acetylation, in vitro acetylation of SOD2 was carried out using 1 lg of recombinant murine SOD2 (Enzo). SOD2 was subjected to nonenzymatic acetylation via acetic anhydride (Sigma) using 3 different concentrations of acetic anhydride (50, 500, and 5,000) (Harris et al., 2017) . SOD2 was incubated with acetic anhydride for 1 hour at room temperature. The samples were then subjected to reducing SDS-PAGE gel electrophoresis using a 12% gel. Once completed in duplicate, one of the gels was used for Western blotting with an antiacetyl antibody (Abcam) and the other one was stained with Coomassie blue where protein bands were visualized and excised from the gel. Isolated protein was then digested with trypsin as previously described . The resulting peptides were desalted using ZipTip C18 tips (EMD Millipore, Darmstadt, Germany) and analyzed by nHPLC coupled to a nano-ESI source on an Impact HD Q-TOF tandem mass spectrometer (Bruker, Billerica, MA). Data analysis was performed using ProteinScape Ò and DataAnalysis software (Bruker).
Computational Modeling
All computational analyses were performed using Accelrys Discovery Studio 4.0 (Biovia, San Diego, CA). The crystal structure coordinates for SOD2 were downloaded from the Protein Data Bank (www.pdb.org; PDB IDs:1MSD) (Wagner et al., 1993) . Figures were rendered using Lightwave 2015.3 (NewTek, Salford, UK).
Statistical Analysis
Statistical analyses including unpaired t-test and graphs were calculated using Prism 6 (GraphPad, La Jolla, CA). Graphs represent the average of 3 independent experiments with error bars indicating the SEM. Results were considered significant if p < 0.05.
RESULTS
Chronic EtOH Feeding Increases Pathological Markers of Liver Damage
To assess the impact of chronic alcohol consumption on relevant pathological markers, we examined liver triglycerides, ALT, body weight, and liver weight to body weight ratio. As a result of chronic EtOH treatment, liver triglyceride levels were significantly increased from 0.025 to 0.058 mmol/l/mg and ALT was increased with EtOH treatment from 25.67 to 141.2 IU/l (Table 1) . These results demonstrated that the initiation of ALD was robust in this model.
Chronic EtOH Metabolism Induces Steatosis, CYP2E1
Expression, and SOD2 Acetyl-K68 in Hepatic Zone 3
Structurally, the liver is divided into 3 zones: Zone 1 is referred to as the periportal zone and surrounds the portal vein, whereas zone 3 is adjacent to the central vein. Zone 2 occupies the transitional region between zones 1 and 3. Chronic EtOH consumption is well known to induce hepatic steatosis and significantly induces the expression of cytochrome P450 2E1 (CYP2E1) in zone 3. H&E staining and IHC were utilized to assess these markers in this model. As shown in Fig. 1 , this chronic EtOH model resulted in steatosis (Fig. 1A) and induced an increase in zone 3 CYP2E1 expression (Fig. 1B) as a result of sustained EtOH metabolism. While mitochondrial protein acetylation has been shown to occur independent of CYP2E1 activation, the zonal distribution of hyperacetylation suggests that EtOH metabolism and resulting hypoxia likely play a role in this marker as an EtOH-induced occurrence (Picklo, 2008) .
Utilizing IHC, we found the majority of SOD2 hyperacetylation to occur in zone 3 of the hepatic lobule (Fig. 1C) and was moderately increased due to EtOH consumption. Global SOD2 analysis by IHC demonstrated that SOD2 expression and distribution remained unaltered between control and EtOH groups (Fig. 1D ). SOD2 and SOD2 acetyl-K68 IHC images were quantified and demonstrate that SOD2 abundance was unchanged between control and EtOH hepatic tissue. Furthermore, IHC quantification revealed that SOD2 acetyl-K68 was increased in the EtOH group; however, the increase did not reach significance (Fig. S1 ). These findings show that SOD2 is hyperacetylated at the regulatory site of lysine 68 predominantly in zone 3, where the majority of hepatic EtOH metabolism occurs (Cederbaum, 2012) . This regional impairment of SOD2 activity suggested that there could be a strong link between EtOH metabolism, protein hyperacetylation, and the pathogenesis of ALD.
EtOH Consumption Results in Depletion of Reduced Glutathione
As oxidative stress plays a major role in ALD, we studied the potential impact of EtOH consumption on GSH/GSSG to determine the role of SOD2 acetylation on liver glutathione redox status. Our results demonstrated that chronic EtOH consumption decreased hepatic GSH levels ( Fig. 2A) without any alteration in GSSG levels (Fig. 2B ), leading to a significant oxidation of the hepatic glutathione redox potential (E h GSSG) (Fig. 2C) . These results show that chronic EtOH consumption induced sustained hepatic oxidative stress, as determined by the depletion of GSH and oxidized redox potential (E h GSSG).
Chronic EtOH Consumption Increases SOD2 Acetylation and Inhibits SOD2 Activity
To elucidate the role of EtOH-induced acetylation on the regulatory sites, K68 and K122, Western blot analyses of liver mitochondrial fractions using anti-SOD2 acetyl-K68 and anti-SOD2 acetyl-K122 antibodies revealed that chronic EtOH consumption increased the acetylation of both residues (Fig. 3A) . Furthermore, total SOD2 protein abundance was unchanged. Immunoblots were quantified and normalized to total SOD2. These results demonstrate that chronic EtOH consumption significantly increased the acetylation of SOD2 K68 by 3-fold and increased the acetylation of SOD2 K122 by 5-fold (Fig. 3B ) compared to pair-fed controls. To investigate the functional impact of lysine hyperacetylation on SOD2 function, an activity assay was performed on liver mitochondrial extract from control and EtOH-fed mice. Compared to the pair-fed control group, chronic EtOH consumption significantly decreased SOD2 activity by 40%, implicating the observed increase in SOD2 lysine acetylation as a potential inhibitory mechanism (Fig. 3C) . A critical aspect of our SOD2 activity assay was that mitochondrial fractions were enriched from whole liver tissue. Accounting for our IHC analysis, inhibition of SOD2 would be much higher around zone 3 where SOD2 hyperacetylation is focused. Additionally, since SOD2 is a reported substrate for the mitochondrial deacetylase SIRT3, we examined the effect of recombinant SIRT3 on mitochondrial lysates from both control and EtOH-fed hepatic murine mitochondrial fractions (Chen et al., 2011) . Figure S2 demonstrates that SIRT3 can remove the EtOH-induced acetylation of SOD2 K68.
EtOH Consumption Alters the Isoelectric Point Profile of SOD2
The positive charge state of certain lysine residues of SOD2 is crucial for enzymatic activity (Zhu et al., 2012) . As acetylation abrogates this charge, acetylated SOD2 would be predicted to both possess decreased enzymatic activity and a change in the isoelectric point of the protein. To assess this, liver mitochondrial extracts from both control-and EtOHfed mice were separated using 2D electrophoresis and probed with anti-SOD2 and anti-SOD2-K68 antibodies. Figure 4 shows that chronic EtOH feeding altered the isoelectric point of SOD2 to a more acidic state (less positively charged), likely due in part to protein acetylation, which would change positively charged lysine residues to a neutral amino acid. These results suggested that chronic EtOH metabolism inhibited the activity of SOD2, in part, by masking many positively charged lysine residues. Previous reports demonstrate that SOD2 is modified on multiple lysine residues by numerous acyl species, including acetylation and succinylation (Weinert et al., 2013) . Acetylation would neutralize the positive charge on lysine while succinylation would switch the charge of that residue from positive to negative, further perturbing the isoelectric point of the SOD2. If this were to occur across many lysine residues on SOD2, in conjunction with other modifications like succinylation and phosphorylation, it would likely result in the broadly smeared band observed in these samples. While these Westerns were probed with a specific acetyl-K68-SOD2 antibody, many other PTMs likely impact the isoelectric point of SOD2. The overall result of myriad acylation events and other PTMs on SOD2 remains a key point of interest for further investigation.
In Vitro Acetylation and Computational Modeling of Recombinant SOD2
To study the mechanisms of SOD2 acetylation, recombinant murine SOD2 was incubated with increasing concentrations (0 to 5 mM) of acetic anhydride. Immunoblotting demonstrated that the resulting acetylation of recombinant Fig. 2 . Chronic ethanol (EtOH) metabolism in a 6-week Lieber-DeCarli model significantly impacts hepatic glutathione homeostasis as determined by (A) a decrease in GSH concentration in EtOH-fed group compared to controls (*p < 0.05), (B) unchanged GSSG levels between groups, and (C) a significantly decreased redox potential in EtOH-fed animals (*p < 0.05). Mean AE SEM, n = 4. SOD2 occurred in a concentration-dependent manner (Fig. 5A) . Liquid chromatography-tandem mass spectrometry (LC-MS/MS) analyses of the acetylated recombinant protein (Fig. 5B ) also confirmed that acetic anhydridemediated acetylation of SOD2 was concentration dependent. The LC-MS/MS results also indicated that K68 is the lysine residue most susceptible to acetylation, suggesting it was a mitochondrial site of allosteric regulation and is susceptible to altered acetylation status in response to mitochondrial metabolic alterations. As anticipated, acetic anhydridemediated acetylation inhibited SOD2 activity by 40, 73, and 63% at 50, 500, and 5,000 lM acetic anhydride, respectively (Fig. 5C ). The locations of each of the major targets of acetylation were highlighted in the SOD2 crystal structure and are colored by relative sensitivity to modification from high (red) to low (yellow) (Fig. 6) . These results illustrate that K68 is highly sensitive to lysine acetylation, suggesting that K68 is a major allosteric site that regulates SOD2 activity among the 8 sites we identified.
In Vivo LC-MS/MS Quantification
To examine the effect of EtOH-induced hepatic mitochondrial protein acetylation on liver SOD2, a quantitative acetylomics approach was employed to determine the relative increase in EtOH-induced acetylation of SOD2 K68. Chronic EtOH consumption resulted in a 5-fold increase in hepatic SOD2 K68 acetylation when compared to controls, which confirmed the results of our Western blot analyses. A representative fragmentation spectra identifying acetyl-K68 of SOD2 demonstrated b-and y-ion coverage of this site of acetylation (Fig. S3) .
DISCUSSION
Oxidative stress and mitochondrial dysfunction are proposed to play a major role in the pathogenesis of ALD . Supporting this overall model, our data demonstrated that as a result of chronic EtOH metabolism hepatic GSH was decreased and E h GSSG was significantly oxidized. SOD2 is a key antioxidant defense enzyme Fig. 3 . Acetylation of SOD2 is increased in hepatic tissue of ethanol (EtOH)-fed mice in this 6-week chronic EtOH model, as shown via (A) Western blot on liver mitochondrial lysates obtained from 3 controls and 3 EtOH-fed mice using specific antibodies against SOD2, SOD2 acetyl-K68, and SOD2 acetyl-K122 and (B) quantification of SOD2 acetyl-K68 (*p < 0.05) and SOD2 acetyl-K122 (**p < 0.01). (C) SOD2 activity was significantly decreased in hepatic mitochondrial fractions of EtOH-fed mice when compared to control animals (*p < 0.05). Mean AE SEM, n = 3. Fig. 4 . Two-dimensional SDS-PAGE is utilized to study the impact of ethanol (EtOH) metabolism on the isoelectric point of SOD2. Liver mitochondrial extracts from both control and EtOH-fed mice were separated using 2D electrophoresis and probed with (A) anti-SOD2 and (B) anti-SOD2 acetyl-K68 antibodies results here reveal that chronic EtOH consumption induces a major shift in the isoelectric point of SOD2 in murine hepatic mitochondria due in large part to protein acetylation and other PTMs.
that protects mitochondria from superoxide radicals and the negative consequences of unchecked free radical species generation (Miao and St Clair, 2009 ). Importantly, SOD2 can be regulated by numerous transcriptional, translational, and posttranslational mechanisms, including protein acetylation (Chen et al., 2011; Gao et al., 2016; Huang et al., 1997; Miao and St Clair, 2009; Qiu et al., 2010) . Specifically, acetylation of K68 and K122, among other sites, can decrease SOD2 activity and remains an interesting target for numerous disease pathologies (Lu et al., 2015; Ozden et al., 2011; Zhu et al., 2012; Zou et al., 2016) .
Our laboratory has recently reported that chronic EtOH consumption induced global SOD2 acetylation (Fritz et al., 2012) . Here, we demonstrated that chronic EtOH consumption altered both SOD2 charge state and activity, in part, through acetylation of K68 and K122. These findings provide new mechanistic insight regarding EtOH-induced hepatic oxidative stress. While EtOH metabolism results in the hyperacetylation of mitochondrial proteins, the exact biochemical mechanism underlying this process remains unknown (Fritz et al., 2012) . Two likely candidate pathways include the following: (i) acetylation derived directly from the breakdown of EtOH via acetaldehyde and acetate and (ii) a secondary effect of altered lipid metabolism and glycolysis impacting acetyl-CoA flux. Importantly, recently published in vivo analyses of mitochondrial sirtuin (SIRT) expression and activity suggest that impaired deacetylation activity is an unlikely candidate pathway (Fritz et al., 2013) . SIRTs are nutrient-sensing, NAD + -dependent deacetylases, and SIRT3 is the primary mitochondrial deacetylase (Chen et al., 2011; Gao et al., 2016; Qiu et al., 2010) . Although SIRT activity is a critical factor in a number of pathologies, a direct role for mitochondrial deacetylase activity in EtOH metabolism remains an intriguing area of investigation (Gertz and Steegborn, 2016) . The data presented here further demonstrate that hyperacetylation of SOD2 inhibits its activity, suggesting a key mechanism contributing to oxidative stress and altered mitochondrial metabolism, all of which are key characteristics of ALD etiology (Armstrong et al., 2004; Gardner, 1997; Murphy et al., 2003; Pias et al., 2003; Vasquez-Vivar et al., 2000) . In 2001, it was reported that SOD2 activity did not change as a result of intragastric alcohol administration in rats (Wheeler et al., 2001 ). However, another study conducted by Ge and colleagues (2013) reported that EtOH metabolism significantly decreased SOD2 activity and Roede and colleagues (2009) demonstrated similar findings, in agreement with our findings. In aggregate, it is apparent that examining SOD2 activity in varying models of alcohol is complicated and further studies are needed to reveal the underlying mechanisms of how EtOH metabolism and resulting epiproteomic alterations regulate SOD2 activity.
Elucidating a role for both global and site-specific mitochondrial protein acetylation remains a key focus toward understanding mitochondrial fidelity during oxidative and metabolic stress due to EtOH metabolism. Deciphering the intricate relationship of lysine acetylation and protein function on a molecular scale remains a complex challenge. Indeed, the charge state of SOD2 is crucial for enzyme activity (Zhu et al., 2012) . Under physiological conditions, the active site of SOD2 exhibits an overall positive charge. This localized positive charge is hypothesized to attract and guide the superoxide anion toward the active site of SOD2. Acetylation of K68 and other lysine residues eliminates this localized positive charge, leading to a reduced affinity of the superoxide anion at the active site (Lu et al., 2015; Zhu et al., 2012) . Importantly, our data demonstrate that chronic EtOH metabolism significantly alters the isoelectric point of hepatic SOD2; however, further studies are needed to explore the impact of lysine acetylation, succinylation, and other PTMs on SOD2 charge-state dynamics and quaternary structure. In addition to SOD2, previous results demonstrate that numerous other antioxidant enzymes are affected by protein hyperacetylation induced by EtOH metabolism (Harris et al., 2015) , such as thioredoxin reductase, glutathione S-transferase, glutathione peroxidase, and glutathione reductase (Fritz et al., 2013) . Further studies are needed to examine the mechanisms by which EtOH-induced protein hyperacetylation impacts these other antioxidantrelated enzymes. While antioxidant therapies have yet to demonstrate effectiveness in ALD, a targeted intervention of antioxidant protein activity such as SOD2 activation may provide a more positive outcome.
In conclusion, the results of this study demonstrate that chronic EtOH consumption impacts SOD2 structure and activity via hyperacetylation. Mass spectrometry, Western blot, and IHC data demonstrate that acetylation of SOD2 was increased as a result of chronic EtOH consumption and that this PTM was enriched in hepatic zones known to be relevant to ALD. Examination of SOD2 activity showed that chronic EtOH consumption and protein hyperacetylation lead to a significant decrease in hepatic SOD2 activity by 40%. Indeed, chronic EtOH metabolism alters the overall charge state of SOD2, as demonstrated by 2D SDS-PAGE. In aggregate, these findings further support the ability of lysine acetylation to alter protein charge-state dynamics and enzymatic function. Additionally, our in vitro analyses demonstrate that K68 appears to be the lysine residue most susceptible to nonenzymatic acetylation and further supports the hypothesis that EtOH-induced protein acetylation plays a role in regulating antioxidant protein function and mitochondrial antioxidant capacity.
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